The disclosure provides salts of (2R,6R)-hydroxynorketamine (HNK), wherein the salt is with an organic acid chosen from malonic acid, salicylic acid, ethane sulfonic acid, glycolic acid, stearic acid, or capric acid, and their crystal forms.

Hydrotropic composition comprising at least one surface active cationic component, which is selected from a group of cholinium, guadinium or tetramethylguadinium, preferably cholinium, and a straight or branched carboxylate anion having at least six carbon atoms; and its uses, for treating of oil sands or the like, for treating tailings from separation of bitumen, asphaltenes or the like.

The instant disclosure provides a process for synthesis of compound of Formula:
X.sub.a-M.sup.z+-Y.sub.b,
wherein M.sup.z+ is a transition metal ion and X and Y are carboxylate anions. The catalysts are hydrocarbon soluble and the process for their preparation, as disclosed herein, constitutes an elegant method for the preparation of such catalysts.

The instant disclosure provides a process for synthesis of compound of Formula:
X.sub.a-M.sup.z+-Y.sub.b,
wherein M.sup.z+ is a transition metal ion and X and Y are carboxylate anions. The catalysts are hydrocarbon soluble and the process for their preparation, as disclosed herein, constitutes an elegant method for the preparation of such catalysts.

The present invention provides polymers, particles, and compositions thereof that selectively and efficiently deliver various therapeutic agents, such as metabolites, to a cell. The present invention further relates to methods relating to the said polymers, particles, and compositions for enhancing biological tissue growth (e.g. biological tissue regeneration in wound healing) in a subject. The present invention additionally provides kits that find use in the practice of the methods of the invention.

The present invention provides polymers, particles, and compositions thereof that selectively and efficiently deliver various therapeutic agents, such as metabolites, to a cell. The present invention further relates to methods relating to the said polymers, particles, and compositions for enhancing biological tissue growth (e.g. biological tissue regeneration in wound healing) in a subject. The present invention additionally provides kits that find use in the practice of the methods of the invention.

The present invention refers to a process for the purification of levulinic acid, an aqueous solution comprising levulinic acid and a process for the production of levulinic acid.

The present invention refers to a process for the purification of levulinic acid, an aqueous solution comprising levulinic acid and a process for the production of levulinic acid.

An autocatalytic process for producing fatty acids from fatty acids methyl esters with an overall conversion higher than 90% which includes multiple hydrolysis reactions in series, in purely thermal conditions, with intermediate separation of phases after each hydrolysis reaction and before the subsequent, operating in excess of water, in order to separate the methanol/water phases from the equilibrium phase and favor the formation of fatty acids product.

An autocatalytic process for producing fatty acids from fatty acids methyl esters with an overall conversion higher than 90% which includes multiple hydrolysis reactions in series, in purely thermal conditions, with intermediate separation of phases after each hydrolysis reaction and before the subsequent, operating in excess of water, in order to separate the methanol/water phases from the equilibrium phase and favor the formation of fatty acids product.